Randomized phase III trial of gefitinib or pemetrexed as second-line treatment in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy (KCSG-LU08-01).

Ahn, M.; Sun, J.; Ahn, J. S.; Kim, S.; Lee, K. H.; Min, Y. J.; Yun, H. J.; Kim, H.; Song, H.; Kim, Y. H.; Kim, B.; Hwang, I. G.; Lee, K.; Woo, I. S.; Ryoo, H.; Lee, K. H.; Yi, H. G.; Jang, J.; Kwon, J. H.; Park, K.

doi:10.1200/jco.2011.29.15_suppl.7603

Detailed Information

Cited 0 time in webofscience

Cited 0 time in scopus

Metadata Downloads

Randomized phase III trial of gefitinib or pemetrexed as second-line treatment in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy (KCSG-LU08-01).

Authors: Ahn, M.; Sun, J.; Ahn, J. S.; Kim, S.; Lee, K. H.; Min, Y. J.; Yun, H. J.; Kim, H.; Song, H.; Kim, Y. H.; Kim, B.; Hwang, I. G.; Lee, K.; Woo, I. S.; Ryoo, H.; Lee, K. H.; Yi, H. G.; Jang, J.; Kwon, J. H.; Park, K.

Issue Date: 20110520

URI: https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/49936

DOI: 10.1200/jco.2011.29.15_suppl.7603

Conference Name: JOURNAL OF CLINICAL ONCOLOGY

Place: 미국
Chicago, IL

Conference Name: 2011 ASCO Annual Meeting

ISSN: 0732-183X
1527-7755

Files in This Item: There are no files associated with this item.

Appears in Collections: 2. Clinical Science > Department of Medical Oncology and Hematology > 2. Conference Papers

Show full item record

qrcode

Altmetrics

Total Views & Downloads

STATISTICS: Total View :13,001,032; Today View :5,950

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Altmetrics

Total Views & Downloads

BROWSE